Cell-wide Metabolic Alterations Associated with Malignancy

Lorenzo Galluzzi (Redaktør) ; Guido Kroemer (Redaktør)

This new volume of Methods in Enzymology continues the legacy of this premier serial with quality chapters authored by leaders in the field. This volume covers research methods providing a a theoretical overview on metabolic alterations of cancer cells and a series of protocols that can be employed to study oncometabolism, in vitro, ex vivo and in vivo. Les mer
Vår pris
2329,-

(Innbundet) Fri frakt!
Leveringstid: Sendes innen 21 dager

Innbundet
Legg i
Innbundet
Legg i
Vår pris: 2329,-

(Innbundet) Fri frakt!
Leveringstid: Sendes innen 21 dager

Om boka

This new volume of Methods in Enzymology continues the legacy of this premier serial with quality chapters authored by leaders in the field. This volume covers research methods providing a a theoretical overview on metabolic alterations of cancer cells and a series of protocols that can be employed to study oncometabolism, in vitro, ex vivo and in vivo.   Malignant cells exhibit metabolic changes when compared to their normal counterparts, owing to both genetic and epigenetic alterations. Although such a metabolic rewiring has recently been indicated as "yet another" general hallmark of cancer, accumulating evidence suggests that the metabolic alterations of each neoplasm rather represent a molecular signature that intimately accompanies, and hence cannot be severed from, all facets of malignant transformation.

Fakta

Innholdsfortegnelse

1. Methods to measure cytoplasmic and mitochondrial Ca2+ concentration using Ca2+-sensitive dyes
2. Methods to measure intracellular Ca2+ fluxes with Organelle-Targeted aequorin-based probes
3. Methods to measure baseline Ca2+ levels with second-generation organelle-targeted fluorescent probes
4. Methods to assess the autophagic flux in malignant cells
5. Methods to assess autophagy in situ-transmission electron microscopy versus immunohistochemistry
6. Methods to measure the enzymatic activity of PI3Ks
7. Luciferase-based reporter to monitor the transcriptional activity of the SIRT3 promoter
8. Metabolomic profiling of cultured cancer cells
9. Pulsed stable isotope-resolved metabolomic studies of cancer cells
10. Single-cell imaging for the study of oncometabolism
11. Study of cellular oncometabolism via multi-dimensional protein identification technology
12. In vivo quantitative proteomics for the study of oncometabolism
13. Metabolomic profiling of neoplastic lesions in mice
14. Metabolomic profiling of tumor-bearing mice
15. Metabolomic studies of patient material by high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy
16. Analysis of metabolomic profiling data acquired on GC–MS

Om forfatteren

Lorenzo Galluzzi is Assistant Professor of Cell Biology in Radiation Oncology at the Department of Radiation Oncology of the Weill Cornell Medical College, Honorary Assistant Professor Adjunct with the Department of Dermatology of the Yale School of Medicine, Honorary Associate Professor with the Faculty of Medicine of the University of Paris, and Faculty Member with the Graduate School of Biomedical Sciences and Biotechnology of the University of Ferrara, the Graduate School of Pharmacological Sciences of the University of Padova, and the Graduate School of Network Oncology and Precision Medicine of the University of Rome “La Sapienza”. Moreover, he is Associate Director of the European Academy for Tumor Immunology and Founding Member of the European Research Institute for Integrated Cellular Pathology.

Galluzzi is best known for major experimental and conceptual contributions to the fields of cell death, autophagy, tumor metabolism and tumor immunology. He has published over 450 articles in international peer-reviewed journals and is the Editor-in-Chief of four journals:
OncoImmunology (which he co-founded in 2011), International Review of Cell and Molecular Biology, Methods in Cell biology, and Molecular and Cellular Oncology (which he co-founded in 2013). Additionally, he serves as Founding Editor for Microbial Cell and Cell Stress, and Associate Editor for Cell Death and Disease, Pharmacological Research and iScience. Guido Kroemer got his M.D. in 1985 from the University of Innsbruck, Austria, and his Ph.D. in molecular biology in 1992 from the Autonomous University of Madrid, Spain. He is currently Professor at the Faculty of Medicine of the University of Paris Descartes/Paris V, Director of the INSERM research team ‘Apoptosis, Cancer and Immunity’, Director of the Metabolomics and Cell Biology platforms of the Gustave Roussy Cancer Campus, and Practitioner at the Hôpital Européen George Pompidou (Paris, France). He is also the Director of the Paris Alliance of Cancer Research Institutes (PACRI) and the Labex 'Immuno-Oncology'. Dr. Kroemer is best known for the discoveries that mitochondrial membrane permeabilization constitutes a decisive step in regulated cell death; that autophagy is a cytoprotective mechanism with lifespan-extending effects; and that anticancer therapies are successful only if they stimulate tumour-targeting immune responses. He is currently the most-cited cell biologist in Europe (relative to the period 2007-2013), and he has received the Descartes Prize of the European Union, the Carus Medal of the Leopoldina, the Dautrebande Prize of the Belgian Royal Academy of Medicine, the Léopold Griffuel Prize of the French Association for Cancer Research, the Mitjavile prize of the French National Academy of Medicine and a European Research Council Advanced Investigator Award.